Japan restarts antibiotic production line 30 years ago.
Rare earths can't be produced, so produce what can be produced first, it seems that Gao Shi is determined to have a go.
Japan has recently restarted an antibiotic raw material production line that had been idle for about 30 years. The Gifu factory of Meiji Seimeikagaku Pharmaceutical was the first to resume production of key penicillin intermediates, with an annual capacity of 200 tons.
This move stems from the fact that Japan's core antibiotic raw materials are almost entirely dependent on imports from China. Geopolitical tensions and past supply disruption crises have left it in a supply chain anxiety. The Japanese government has invested heavily in subsidies to promote domestic production, aiming to build an independent supply system by 2030, but faces challenges such as high costs, lack of skilled workers, and an incomplete industrial chain, making it difficult to摆脱 reliance on China in the short term.
Original: toutiao.com/article/1855732062646472/
Statement: This article represents the personal views of the author.